Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 10, 2012
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotypeRoger M Lane, Yunsheng HeMedical Hypotheses|April 11, 2009
Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementiasRoger M Lane, Yunsheng HeApplied Optics|May 3, 2023
Analysis of image motion for optical remote sensing satellites staring imaging with area-array detectorsJiantao Peng, Yunsheng He, Lianyu Zheng, et al.Discover Oncology|November 20, 2025
Non-coding RNAs in programmed cell death regulation in melanoma: mechanisms and therapeutic insightsYang Liu, Chenqi Guo, Yunsheng He, et al.Geriatrics & Gerontology International|February 12, 2026
Development and Validation of a Risk Prediction Model for Digestive Tract Diseases in Chinese Patients With DepressionXinming Chen, Chenxiong Zhang, Yunsheng He, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive declineRoger Lane, Yunsheng He, Christopher Morris, et al.Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.Discover Oncology|November 13, 2024
Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER program-based studyXinming Chen, Pingwu Zhao, Yunsheng He, et al.Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.Pharmacogenetics and Genomics|October 19, 2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's diseaseRafael Blesa, Roger Bullock, Yunsheng He, et al.Pageof 3